PTGS2 and colorectal cancer: Genetic variants of Cox-2 with nonsynonymous single-nucleotide polymorphisms (SNPs) in the coding region may have altered specificity, function, and/or interaction with NSAIDs, and may contribute to colorectal cancer risk.